TERADX
Contact information
- Biomarkers
- In vitro diagnostics
- Oncology
Our mission is to develop innovative diagnostic solutions based on molecular biomarkers and human microbiome analysis, with the aim of improving early detection and supporting clinical decision-making in complex diseases. We focus on translational research, technological innovation, and rigorous scientific validation to generate real impact in clinical practice.
We develop in vitro diagnostic tools based on bacterial DNA (16S rDNA) sequence analysis and microbial profiling from non-invasive samples such as saliva. Our products are focused on the identification of microbial signatures associated with pathological conditions and on the development of supportive diagnostic solutions for clinical use.
We are interested in collaborations with biotechnology companies, research centers, hospitals, and industrial partners in areas such as molecular diagnostics, microbiome research, oncology, clinical validation, regulatory development (IVDR), and technology transfer. We are also open to strategic alliances for R&D projects, clinical studies, and industrial scale-up.